15 JAHRE NIV - WO STEHEN WIR - Atmung/Beatmung Dirk Jahnke
15 JAHRE NIV - WO STEHEN WIR - Atmung/Beatmung Dirk Jahnke
15 JAHRE NIV - WO STEHEN WIR - Atmung/Beatmung Dirk Jahnke
- TAGS
- dirk
- jahnke
- atmungbeatmung.de
Transform your PDFs into Flipbooks and boost your revenue!
Leverage SEO-optimized Flipbooks, powerful backlinks, and multimedia content to professionally showcase your products and significantly increase your reach.
<strong>15</strong> <strong>JAHRE</strong> <strong>NIV</strong> - <strong>WO</strong> <strong>STEHEN</strong> <strong>WIR</strong><br />
Mittwoch, 22. Februar 12<br />
<strong>Dirk</strong> <strong>Jahnke</strong><br />
Fachkrankenpfleger A&I<br />
Klinikum Oldenburg
Mittwoch, 22. Februar 12<br />
<strong>15</strong> Jahre ?<br />
Meduri GU, Conoscenti CC, Menashe P, et al. Noninvasive face<br />
mask ventilation in patients with acute respiratory failure. Chest<br />
1989; 95:865-870
Mittwoch, 22. Februar 12<br />
nicht repräsentative Zahlen<br />
Teilnehmer ?<br />
Wann wird <strong>NIV</strong> eingesetzt ?<br />
Was ist <strong>NIV</strong> ?<br />
Definition „Klappt“ ?<br />
subjektive Aussage !<br />
www.atmungbeatmung.de
Mittwoch, 22. Februar 12<br />
Fragebogenaktion 2003<br />
Umfrage zum Stellenwert der non-invasiven Ventilation auf Deutschen Intensivstationen.<br />
Kumle B et al. –Anästhesiol Intensivmed Notfallmed Schmerzther 2003; 38: 32 -37<br />
n = 223 Intensivstationen<br />
13% lehnten <strong>NIV</strong> ab<br />
Gründe :<br />
11% Risiko<br />
4% Kosten<br />
57% Personalaufwand<br />
4% kein Vorteil<br />
64% kein Gerät
Mittwoch, 22. Februar 12<br />
Arzt / Ärztin<br />
Fachpflegekraft<br />
(Atemtherapeut)<br />
(17.7% for MD, 23.1% for N, and 10.7% for RT).<br />
recorded and divided into direct and indirect components. These<br />
The time elapsed, during the first 30 to 60 min, in Figure 3. N an<br />
data were recorded from a computer-based system developed by<br />
the group that failed NIMV and spent in trying to period of MV.<br />
our hospital. Direct costs were considered to be incurred by<br />
InMV; two aste<br />
diagnostic tests and studies (ie, radiologic studies, hematologic<br />
deliver this modality of ventilation was also recorded.<br />
tests, and pulmonary function tests), disposable supplies (phar-<br />
The addition of these minutes of assistance<br />
macy, personnel supplies), and medical and paramedical salaries.<br />
(16.4�4.6 min for Ns, 25.2�6.6 min for RTs, and<br />
The 48-h indirect cost per patient was calculated as recently<br />
24.8�4.2 min for MDs) did not, however, signifi- noninvasivel<br />
described by Criner and coworkers<br />
cantly increase the staff’s total workload per patient tients) throu<br />
weaning occu<br />
fail the initial NIMV trial.<br />
and MDs sh<br />
Figure 3 shows the minutes spent per day by Ns after the firs<br />
and MDs in the care of the patients ventilated time, respec<br />
As shown<br />
not significa<br />
tients, even<br />
lated patient<br />
table illustra<br />
Group A<br />
Group B<br />
Category<br />
Personnel<br />
Radiograph<br />
Drug<br />
Supplies<br />
Laboratory<br />
Indirect costs<br />
Figure 2. Workload of the whole medical and paramedical Others<br />
personnel (total), Ns, MDs, and RTs, expressed as a percentage<br />
of the first 48 h of MV. Data are mean�SD. Asterisk indicates *Total costs of t<br />
p�0.05 between NIMV and InMV.<br />
costs (upper pa<br />
Human and financial costs of noninvasive<br />
Downloaded from www.chestjournal.org by on Ju<br />
mechanical ventilation in patients affected by<br />
COPD and acute respiratory failure<br />
S Nava, I Evangelisti, C Rampulla, ML<br />
Compagnoni, C Fracchia and F Rubini Chest<br />
1997;111;1631-1638<br />
11 recorded and divided into direct and indirect components. These<br />
data were recorded from a computer-based system developed of variance by for repeated measurements. Statistical significance<br />
our hospital. Direct costs were considered to be incurred was defined by as a two-tailed p value �0.05.<br />
diagnostic tests and studies (ie, radiologic studies, hematologic<br />
tests, and pulmonary function tests), disposable supplies (pharmacy,<br />
personnel supplies), and medical and paramedical salaries.<br />
The 48-h indirect cost per patient was calculated as recently<br />
Results<br />
described by Criner and coworkers<br />
As illustrated in Table 2, the institution of both<br />
as the daily rate of reimbursement<br />
for each full-time staff position assigned only to NIMV and InMV improved the arterial blood gas<br />
patients in the RICU. Indirect costs included overhead to cover values of the patients by hospital discharge, although<br />
some institutional services such as laundry, heating, nondispos- one patient from each group died before the weanable<br />
equipment (ventilators, monitors, arterial blood gas analyzing. The group A patient died of pneumonia on day<br />
ers). The data were expressed in US dollars after having con-<br />
9. Multiple organ failure was the cause of death for<br />
verted the costs from Italian lira (1 US dollar�1,590 Italian lire).<br />
Results are expressed as mean�SD. Comparisons between the the group B patient on day 7.<br />
two groups of patients were performed with a two-sample t test, The upper part of Figure 1 illustrates the total Ns<br />
while short- (48 h) and long-term (until hospital discharge) workload per patient in the first 48 h of MV. No<br />
comparison measurements were analyzed using two-way analysis significant differences were observed in the time of<br />
assistance between the NIMV and InMV patients.<br />
After the first 6 h, there was, however, a common<br />
significant decrease in the two groups that reached a<br />
plateau after 12 h of mechanical ventilation (MV).<br />
The total time of nursing assistance for each patient<br />
in the first 48 h for group A was 540.1�76.4 min vs<br />
527.5�51.1 min for group B (not significant). Table<br />
3 shows the activities related to MV.<br />
The middle part of Figure 1 illustrates the total MDs<br />
workload per patient in the first 48 h of ventilation. The<br />
total time expenditure for MD was 4<strong>15</strong>�110 min for<br />
group A vs 524�<strong>15</strong>6 min for group B (not significant).<br />
The MDs activities that required more time were<br />
similar for the NIMV and the InMV groups (Table 4).<br />
As shown in the lower panel of Figure 1, there was a<br />
significant difference in the total RTs workload per<br />
patient in group A during the first 6 h. While this time<br />
decreased significantly after this period of time during<br />
NIMV, it remained constant in the InMV group<br />
throughout the first 48 h.<br />
The total time of assistance per patient given by<br />
RTs in the first 48 h was 250.8�66.5 min for group<br />
A vs 72.7�38.5 min for group B. The total time of<br />
assistance per patient given by Ns, RTs, and MDs in<br />
the first 48 h was 1,205.67�<strong>15</strong>4.07 min vs<br />
1,126�177.69 min for group A and B, respectively.<br />
11 of variance for repeated measurements. Statistical significance<br />
was defined as a two-tailed p value �0.05.<br />
Results<br />
As illustrated in Table 2, the institution of both<br />
as the daily rate of reimbursement<br />
for each full-time staff position assigned only to NIMV and InMV improved the arterial blood gas<br />
patients in the RICU. Indirect costs included overhead to cover values of the patients by hospital discharge, although<br />
some institutional services such as laundry, heating, nondispos- one patient from each group died before the weanable<br />
equipment (ventilators, monitors, arterial blood gas analyzing. The group A patient died of pneumonia on day<br />
ers). The data were expressed in US dollars after having con-<br />
9. Multiple organ failure was the cause of death for<br />
verted the costs from Italian lira (1 US dollar�1,590 Italian lire).<br />
Results are expressed as mean�SD. Comparisons between the the group B patient on day 7.<br />
two groups of patients were performed with a two-sample t test, The upper part of Figure 1 illustrates the total Ns<br />
while short- (48 h) and long-term (until hospital discharge) workload per patient in the first 48 h of MV. No<br />
comparison measurements were analyzed using two-way analysis significant differences were observed in the time of<br />
assistance between the NIMV and InMV patients.<br />
After the first 6 h, there was, however, a common<br />
significant decrease in the two groups that reached a<br />
plateau after 12 h of mechanical ventilation (MV).<br />
The total time of nursing assistance for each patient<br />
in the first 48 h for group A was 540.1�76.4 min vs<br />
527.5�51.1 min for group B (not significant). Table<br />
3 shows the activities related to MV.<br />
The middle part of Figure 1 illustrates the total MDs<br />
workload per patient in the first 48 h of ventilation. The<br />
total time expenditure for MD was 4<strong>15</strong>�110 min for<br />
group A vs 524�<strong>15</strong>6 min for group B (not significant).<br />
The MDs activities that required more time were<br />
similar for the NIMV and the InMV groups (Table 4).<br />
As shown in the lower panel of Figure 1, there was a<br />
significant difference in the total RTs workload per<br />
patient in group A during the first 6 h. While this time<br />
decreased significantly after this period of time during<br />
NIMV, it remained constant in the InMV group<br />
throughout the first 48 h.<br />
The total time of assistance per patient given by<br />
RTs in the first 48 h was 250.8�66.5 min for group<br />
A vs 72.7�38.5 min for group B. The total time of<br />
assistance per patient given by Ns, RTs, and MDs in<br />
the first 48 h was 1,205.67�<strong>15</strong>4.07 min vs<br />
1,126�177.69 min for group A and B, respectively.<br />
in group B, as compared to the patients who did not<br />
Personal - Aufwand<br />
Table 3—Description of N Workload*<br />
Table 3—Description of N Workload*<br />
NIMV % InMV %<br />
NIMV %<br />
Logging of vital signs<br />
InMV %<br />
28 Logging of vital signs 23<br />
Logging of vital signs Assistance to28 NIMV Logging of vital 21signs Endotracheal23 suctions 20<br />
Assistance to NIMV Administration 21of Endotracheal therapy suctions 14 Administration 20of<br />
therapy <strong>15</strong><br />
Administration of Hygiene therapy of the 14 patient’s Administration body 12 of Change therapy of the <strong>15</strong>linens<br />
12<br />
Hygiene of the patient’s Changebody of the 12linens Change of the linens 9 Hygiene of the 12 patient’s body 11<br />
Change of the linens Treatment for9nose Hygiene skin of the 6patient’s Sampling body and11management 9<br />
Treatment for nose skin abrasions 6 Sampling and management of biochemistry 9 tests<br />
abrasions Others of biochemistry 10 Others tests<br />
10<br />
Figure 1. Ns, MDs, and RTs, workload in the first 48<br />
Others<br />
h of MV.<br />
10 Others 10<br />
Figure 1. Ns, MDs, Dataand areRTs, mean�SD. workloadAsterisk in the first indicates 48 h of p�0.05 MV. compared with *The activities are expressed as a percentage of the total amount of<br />
Data are mean�SD. the first Asterisk 6-h period. indicates p�0.05 compared with *The activities are expressed workload in asthe a percentage first 48 h. of the total amount of<br />
the first 6-h period.<br />
workload in the first 48 h.<br />
1634 Clinical Investigations in Critical Care<br />
1634 Downloaded from www.chestjournal.org by on July Clinical 8, 2005 Investigations in Critical Care<br />
Downloaded from www.chestjournal.org by on July 8, 2005
<strong>NIV</strong> - Indikation - Parameter<br />
Hyperkapnisches Atempumpversagen<br />
Mittwoch, 22. Februar 12<br />
pH < 7,35 (pH > 7,2 )<br />
pCO2 > 50<br />
hypoxämischen ARI - weiter unklare Datenlage
<strong>NIV</strong> - Indikation - Parameter<br />
Hyperkapnisches Atempumpversagen<br />
Mittwoch, 22. Februar 12<br />
pH < 7,35 (pH > 7,2 )<br />
pCO2 > 50<br />
hypoxämischen ARI - weiter unklare Datenlage
Begriffe CPAP vs. <strong>NIV</strong><br />
CPAP-Maske <strong>NIV</strong><br />
Atemhilfe<br />
<strong>Beatmung</strong> ohne invasiven Zugang<br />
Mittwoch, 22. Februar 12<br />
keine aktive Unterstützung<br />
der Atempumpe<br />
pH > 7,35 pCO2 < 50<br />
höherer Totraum<br />
Verbesserung der<br />
Ausgangssituation<br />
/ weniger Atemarbeit<br />
Fragebogenaktion 2003 - 25% „Was ist <strong>NIV</strong>?“ : CPAP Maske<br />
aktive Entlastung der Atempumpe<br />
pH < 7,35 pCO2 > 50<br />
höherer Totraum wird durch<br />
<strong>Beatmung</strong> kompensiert<br />
Verbesserung der<br />
Ausgangssituation<br />
/ weniger - keine Atemarbeit
Evidence<br />
Mittwoch, 22. Februar 12<br />
<strong>NIV</strong>-Indikation<br />
exazerbierte COPD - 82 %<br />
neuromuskuläre Erkrankungen<br />
akutes Lungenödem (4,5) - 50%<br />
nach Extubation / fortgesetztes Weaning<br />
immunsupprimierte Patienten mit ARI<br />
zur Präoxygenierung vor Intubation bei Hypoxämie (6)<br />
Pneumonie 64%<br />
ARDS - 22%<br />
XX % von 223 Intensivstationen - <strong>NIV</strong> bei ...<br />
Umfrage zum Stellenwert der non-invasiven Ventilation auf Deutschen Intensivstationen
Mittwoch, 22. Februar 12<br />
Kontraindikationen <strong>NIV</strong><br />
absolute Kontraindikationen<br />
Apnoe / Schnappatmumg /<br />
Herzkreislaufstillstand<br />
GI Blutung / Ileus - Apsirationsgefahr<br />
Verlegung der Atemweg<br />
Experten Meinung !<br />
Leitlinie „Nichtinvasive <strong>Beatmung</strong> als Therapie der akuten respiratorischen<br />
Insuffizienz“<br />
relative Kontraindikationen<br />
(hyperkapnisches) Koma (2)<br />
massive Agitation<br />
Instabile Hämodynamik<br />
Sekretverhalt<br />
Unmöglichkeit die Maske zu platzieren<br />
Schwergradige Hypoxämie oder Azidose (pH < 7,1)<br />
Z.n. oberer gastrointestinaler OP
Mittwoch, 22. Februar 12<br />
Modi <strong>NIV</strong><br />
PCV (BiLevel / BIPAP / BIPAPassist /ST)<br />
PSV (DU / PS / ASB)<br />
max Entlastung der Atempumpe möglich<br />
Triggerung möglich<br />
„Abholen“ des Patienten möglich
Mittwoch, 22. Februar 12<br />
Intensivrespirator<br />
optimierter <strong>NIV</strong> Respirator<br />
schneller Wechsel auf invasiv<br />
Mitarbeiterschulung<br />
Sicherheit am Gerät<br />
Technik<br />
freie Alarmgrenzen<br />
optimierte <strong>Beatmung</strong>smodi<br />
Triggerung bei Maskeneinsatz<br />
Anschaffungskosten<br />
(Kosten / <strong>Beatmung</strong>sstunde)<br />
Platzbedarf
Mittwoch, 22. Februar 12<br />
pH steigt , pCO2 fällt<br />
Erfolgskriterien<br />
bessere Oxygenierung (bei niedrigem FiO2 indirektes Zeichen für bessere<br />
Ventilation)<br />
AF sinkt<br />
Bewussteinszustand verbessert sich<br />
Atemmechanik verbessert sich<br />
Hämodynamik stabilisiert sich<br />
Schwitzen lässt nach<br />
Kooperation und Toleranz<br />
innerhalb von<br />
1-2 Stunden<br />
Erfolg nicht vorhersagbar
Mittwoch, 22. Februar 12<br />
Spo2 < 85% bei FiO2 >0,5<br />
pCO2 steigt über initialen Wert<br />
pH Abfall<br />
Sekretverhalt<br />
Aspiration<br />
mangelnde Kooperation<br />
Abbruch<br />
Zunahme der Agitiertheit bzw. Verschlechterung des Bewusstseins<br />
(Unfähigkeit sich die Maske zu entfernen)<br />
jederzeit - wenn<br />
keine Anpassung<br />
möglich
Mittwoch, 22. Februar 12<br />
Aussichten<br />
aktuelle Stellensituation im ICU Bereich -<br />
Qualifizierung / Fluktuation im Intensivbereich -<br />
Studien aus pflegerischer Sicht +<br />
Arbeiten nach Algorithmen +<br />
Atemtherapeut +
ENDE<br />
Danke für ihre Aufmerksamkeit !<br />
Mittwoch, 22. Februar 12<br />
<strong>Dirk</strong> <strong>Jahnke</strong> - www.atmungbeatmung.de<br />
1. S3 – Leitlinie -Nichtinvasive <strong>Beatmung</strong> als Therapie der akuten respiratorischen Insuffizienz<br />
2.Diaz GG, Alcaraz AC, Talavera JC, et al. Noninvasive positive-pressure ventilation to treat hypercapnic coma secondary to respiratory failure. Chest 2005; 127:952-960<br />
3.Ram FS, Wellington S, Rowe BH, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev<br />
2005:CD004360<br />
4.AJ Gray, S Goodacre,A multicentre randomised controlled trial of the use of continuous positive airway pressure and noninvasive positive pressure ventilation in the early treatment of patients prese<br />
nting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial - Health Technology Assessment 2009; Vol. 13: No. 33<br />
5.J Card Fail. 2011 Oct;17(10):850-9. Epub 2011 Jul 8.- Noninvasive ventilation in acute cardiogenic pulmonary edema: a meta-analysis of randomized controlled trials.<br />
6.Baillard C, Fosse JP, Sebbane M, et al. Noninvasive Ventilation Improves Preoxygenation before Intubation of Hypoxic Patients. Am J Respir Crit Care Med 2006; 174:171-177<br />
7.Winck JC, Azevedo LF, Costa-Pereira A, et al. Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema - a systematic review and meta- analysis. Crit Care<br />
2006; 10:R69<br />
8.Hilbert G, Gruson D, Portel L, et al. Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency. Eur Respir J 1998; 11:1349-1353<br />
9.Hilbert G, Gruson D, Vargas F, et al. Noninvasive continuous positive airway pressure in neutropenic patients with acute respiratory failure requiring intensive care unit admission. Crit Care Med 2000;<br />
28:3185-3190<br />
10.Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998;<br />
339:429-435<br />
11.Girou E, Brun-Buisson C, Taille S, et al. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema.<br />
JAMA 2003; 290:2985-2991<br />
12.Umfrage zum Stellenwert der non-invasiven Ventilation auf Deutschen Intensivstationen - Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. - Stuttgart [u.a.] : Thieme Vol. 38, No. 01<br />
(1. 2003), p. 32-37<br />
13. Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acutt respiratory failure S Nava, I Evangelisti, Chest 1997;111;1631-1638